ZA200707970B - Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis - Google Patents
Compositions of HSP60 peptides and viral antigens for vaccination and diagnosisInfo
- Publication number
- ZA200707970B ZA200707970B ZA200707970A ZA200707970A ZA200707970B ZA 200707970 B ZA200707970 B ZA 200707970B ZA 200707970 A ZA200707970 A ZA 200707970A ZA 200707970 A ZA200707970 A ZA 200707970A ZA 200707970 B ZA200707970 B ZA 200707970B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccination
- diagnosis
- compositions
- viral antigens
- hsp60 peptides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6043—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66101705P | 2005-03-14 | 2005-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707970B true ZA200707970B (en) | 2008-11-26 |
Family
ID=36992117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707970A ZA200707970B (en) | 2005-03-14 | 2006-02-21 | Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis |
Country Status (7)
Country | Link |
---|---|
US (3) | US20080279878A1 (de) |
EP (2) | EP2402022B1 (de) |
AU (1) | AU2006224216B2 (de) |
CA (1) | CA2601518A1 (de) |
ES (1) | ES2389849T3 (de) |
WO (1) | WO2006097914A2 (de) |
ZA (1) | ZA200707970B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007116409A2 (en) * | 2006-04-11 | 2007-10-18 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Improved vaccines comprising multimeric hsp60 peptide carriers |
US9345753B2 (en) | 2008-01-16 | 2016-05-24 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Vaccine for alzheimer's disease |
GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
PH12013000059A1 (en) * | 2013-02-15 | 2016-12-12 | Yu Gracia Fe | Diagnosis and detection of dengue virus infection using chicken egg antibodies |
CN103880962B (zh) * | 2014-03-19 | 2016-01-06 | 国家纳米科学中心 | 融合蛋白及其编码基因和制备方法以及一种药物组合物及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073943A (en) | 1974-09-11 | 1978-02-14 | Apoteksvarucentralen Vitrum Ab | Method of enhancing the administration of pharmalogically active agents |
US4168308A (en) | 1976-03-12 | 1979-09-18 | Apoteksvarucentralen Vitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
NL8701163A (nl) | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
NL8703107A (nl) | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
US5114844A (en) | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
US5736146A (en) * | 1992-07-30 | 1998-04-07 | Yeda Research And Development Co. Ltd. | Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5869058A (en) * | 1994-05-25 | 1999-02-09 | Yeda Research And Development Co. Ltd. | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
IL109790A0 (en) * | 1994-05-25 | 1994-08-26 | Yeda Res & Dev | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
BR0206995A (pt) * | 2001-02-05 | 2005-08-16 | Stressgen Biotechnologies Corp | Tratamento do vìrus da hepatite b |
JP2005532981A (ja) * | 2001-09-25 | 2005-11-04 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 免疫媒介疾患における病原性免疫応答を調節するためのエピトープ特異的およびサイトカイン/抗サイトカイン併用免疫治療法 |
WO2004016586A2 (en) * | 2002-08-16 | 2004-02-26 | Board Of Regents The University Of Texas System | Compositions and methods related to flavivirus envelope protein domain iii antigens |
-
2006
- 2006-02-21 US US11/908,474 patent/US20080279878A1/en not_active Abandoned
- 2006-02-21 WO PCT/IL2006/000222 patent/WO2006097914A2/en active Application Filing
- 2006-02-21 ZA ZA200707970A patent/ZA200707970B/xx unknown
- 2006-02-21 EP EP11165324.2A patent/EP2402022B1/de not_active Not-in-force
- 2006-02-21 EP EP06711204A patent/EP1858548B1/de not_active Not-in-force
- 2006-02-21 AU AU2006224216A patent/AU2006224216B2/en not_active Ceased
- 2006-02-21 CA CA002601518A patent/CA2601518A1/en not_active Abandoned
- 2006-02-21 ES ES06711204T patent/ES2389849T3/es active Active
-
2011
- 2011-06-20 US US13/164,411 patent/US8652439B2/en not_active Expired - Fee Related
-
2014
- 2014-01-02 US US14/146,549 patent/US20140120126A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2389849T3 (es) | 2012-11-02 |
US8652439B2 (en) | 2014-02-18 |
WO2006097914A3 (en) | 2007-01-04 |
EP1858548A2 (de) | 2007-11-28 |
EP2402022A3 (de) | 2012-04-25 |
EP1858548B1 (de) | 2012-06-20 |
AU2006224216A1 (en) | 2006-09-21 |
WO2006097914A2 (en) | 2006-09-21 |
AU2006224216B2 (en) | 2011-12-08 |
EP2402022A2 (de) | 2012-01-04 |
EP2402022B1 (de) | 2014-10-29 |
EP1858548A4 (de) | 2009-03-11 |
CA2601518A1 (en) | 2006-09-21 |
US20080279878A1 (en) | 2008-11-13 |
US20110256165A1 (en) | 2011-10-20 |
US20140120126A1 (en) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2089053A4 (de) | Hpv-antigen-fusionsprotein-impfstoff-zusammenstzungen und ihre verwendungen | |
HRP20170024T1 (hr) | Antigeni peptidi gm-csf i protutijela protiv gm-csf | |
HK1211606A1 (en) | Identification of tumor-associated antigens for diagnosis and therapy | |
ZA200810456B (en) | Lyophilized formulations of anti-EGFR antibodies | |
ZA201002160B (en) | Human gm-csf antigen binding proteins | |
IL193397A0 (en) | Hpv antigens, vaccine compositions, and related methods | |
EP1948227A4 (de) | Kombinatorische antigen-vakzine gegen grippe | |
EP2006377A4 (de) | Neue tumorantigenpeptide | |
AU2003246373A8 (en) | Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions | |
EP1890720A4 (de) | Pharmazeutische zusammensetzungen mit von casein stammenden peptiden und anwendungsverfahren dafür | |
IL205398A0 (en) | New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs | |
EP1934335A4 (de) | Modifizierte tabak-mosaikvirus-teilchen als gerüste zur anzeige von protein-antigenen für impfstoff-anwendungen | |
HK1219052A1 (zh) | 針對典型性豬瘟病毒的嵌合疫苗抗原 | |
ZA200707970B (en) | Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis | |
EP1957652A4 (de) | Pro-apoptose-bakterien und zusammensetzungen zur lieferung und expression von antigenen | |
EP1871786A4 (de) | Peptidimpfstoff gegen das grippevirus | |
ZA201101743B (en) | Vaccine comprising protein nmbo964 from meisseria meningitidis | |
ZA200803664B (en) | Chimeric antigens and vaccines | |
IL185932A0 (en) | Compositions of hsp60 peptides and viral antigers for vaccination and diagnosis | |
EP2012829A4 (de) | Verfahren zur herstellung eines viralen impfstoffes und therapeutischer peptid-antigene | |
EP2024538A4 (de) | Zusammensetzungen und verfahren zur identifizierung von antigenen | |
ZA200710374B (en) | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof | |
IL185772A0 (en) | Antigen specific lymphocytes, compositions thereof, and methods for isolation and preparation thereof | |
IL222485A (en) | Medical preparations that contain peptide-derived peptides and methods for their use | |
IL187120A0 (en) | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |